ARWR Market Cap History
Below is a table of the ARWR market cap history going back to 11/17/2011:

Date ARWR Market Cap
11/17/201143.32M
12/15/201148.63M
2/1/201253.18M
5/1/201262.46M
8/3/201241.85M
12/21/201232.23M
2/8/201332.72M
5/7/201367.18M
8/5/2013132.78M
12/16/2013338.24M
1/31/2014608.80M
5/1/2014585.12M
8/11/2014679.88M
11/24/2014337.12M
2/5/2015366.01M
5/8/2015418.87M
7/31/2015367.72M
12/11/2015335.89M
2/5/2016206.31M
5/9/2016345.37M
8/8/2016358.43M
12/12/201694.94M
2/3/2017141.68M
5/2/2017116.64M
8/1/2017128.61M
12/6/2017258.91M
2/7/2018508.58M
5/7/2018680.47M
8/6/20181.25B
12/7/20181.21B
2/6/20191.30B
5/6/20191.76B
8/2/20192.78B
11/20/20194.63B
2/3/20204.40B
5/5/20203.60B
7/27/20204.94B

Also see: ARWR Shares Outstanding History
and ARWR YTD Return
ARWR Historical Market Cap:
+72.43% CAGR
ARWR Historical Market Cap: +72.43% CAGR

Mouse over chart for data details
11/17/2011 ...7/27/2020
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a portfolio of RNA chemistries and several modes of delivery, Co.'s therapies trigger the RNA interference (RNAi) mechanism to induce knockdown of target genes. Co. is focused on developing drugs for diseases with a genetic basis, typically characterized by the overproduction of one or more proteins that are involved with disease. Co.'s pipeline includes, among others, ARO-AAT, a candidate for the treatment of liver disease, and ARO-APOC3, which is designed to reduce production of Apolipoprotein C-III, a component of triglyceride rich lipoproteins. We show 37 historical shares outstanding datapoints in our ARWR shares outstanding history coverage, used to compute ARWR market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ARWR market cap history over the course of time is important for investors interested in comparing ARWR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ARWR versus a peer is one thing; comparing ARWR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ARWR can fluctuate over the course of history. With this page we aim to empower investors researching ARWR by allowing them to research the ARWR market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ARWR:
ARWR SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Arrowhead Pharmaceuticals (ARWR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ASMB Market Cap History
ASNS Market Cap History
ATEC Market Cap History
ATHX Market Cap History
ATNX Market Cap History
ATOS Market Cap History
ATRA Market Cap History
ATRC Market Cap History
ATRI Market Cap History
ATRS Market Cap History
More Healthcare companies »

 

ARWR Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.